GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,052,000 | -5.1% | 93,032 | -3.9% | 1.67% | +0.2% |
| Q4 2021 | $4,269,000 | +18.2% | 96,809 | +2.4% | 1.66% | +2.0% |
| Q3 2021 | $3,611,000 | -2.3% | 94,499 | +1.8% | 1.63% | -1.6% |
| Q2 2021 | $3,695,000 | +12.3% | 92,790 | +0.7% | 1.66% | +2.9% |
| Q1 2021 | $3,290,000 | -2.9% | 92,178 | +0.1% | 1.61% | -9.3% |
| Q4 2020 | $3,390,000 | -2.8% | 92,110 | -0.5% | 1.78% | -14.9% |
| Q3 2020 | $3,486,000 | – | 92,610 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |